While spine ependymomas (including those with NF2 mutation) are, in general, regarded as good prognosis [34], MYCN-amplified spinal ependymomas in particular exhibit aggressive behavior, rapid progression, early metastases, and leptomeningeal dissemination. The gene discussed is MYCN; the disease is ependymoma.